Cargando…
Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data
BACKGROUND: The global burden of cardiovascular disease (CVD) continues to rise. Successful treatment of CVD requires adequate pharmaceutical management. The aim was to examine the availability, pricing and affordability of cardiovascular medicines in developing countries using the standardized data...
Autores principales: | van Mourik, Maaike SM, Cameron, Alexandra, Ewen, Marg, Laing, Richard O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898673/ https://www.ncbi.nlm.nih.gov/pubmed/20534118 http://dx.doi.org/10.1186/1471-2261-10-25 |
Ejemplares similares
-
Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology
por: Sharma, Abhishek, et al.
Publicado: (2016) -
Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology
por: Saeed, Amna, et al.
Publicado: (2021) -
Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019) -
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
por: Sisay, Mekonnen, et al.
Publicado: (2021) -
Availability, price, and affordability of medicines used for the management of Covid-19 in health facilities of Dessie town WHO/HAI survey
por: Mohammed, Solomon Ahmed, et al.
Publicado: (2022)